同被引文献21
1 余晋荣.盐酸坦索罗辛的临床应用[J] .海峡药学,2006,18(1):143-145. 被引量:6
2 Imai K,Fujikura T,Hashimoto S,et al.Phenethylaminederivatives[P].FR:2487827,1982-02-05.(CA 1982,97:38659)
3 Imai K,Niigata K,Fujikura T,et al.Phenylethanolamine derivatives[P].DE:2843016,1979-04-26.(CA 1979,91:157445)
4 Niigata K,Fujikura T.Sulfamoyl-substituted phenethylamine derivatives with α-adrenergic blocking activity for use as antihypertensives,and their pharmaceutical compositions[P].US:4731478,1988-03-15.(CA 1989,110:153907)
5 Imai K,Niigata K,Fujikura T,et al.Sulfamoyl-substituted phenethylamine derivatives,and pharmaceutical composition,containing them[P].EP:34442,1981-08-26.(CA 1982,96:19812)
6 Hoorn HJ,Peters THA,Pis J.Racemic tamsulosin free base and methods of making the same[P].WO:2003037851,2003-05-08.(CA 2003,138:368611)
7 Hradil P,Urbasek M,Kvapil L,et al.Process for preparing Rand S-isomers of (R) -5-(2-((2-(2-ethoxyphenoxy) ethyl)amino) propyl)) -2-methoxybenzenesulfonamide[P].US:2005/0079589,2005-04-14.(CA 2005,142:392174)
8 Sakurai S,Mitani K,Hashimoto S.et al.Novel phenoxyalkylamine derivatives.Ⅶ.Synthesis and pharmacological activities of 2-alkoxy-5-[(phenoxyalkylamino) alkyl]benzenesulfonamide derivatives[J].Chem Pharm Bull,1992,40 (6):1443-1451.
9 Yamanouchi Pharmaceutical Co.,Ltd.5-(oAlkoxyphenoxyethylaminoethyl) -2-methoxy (or methyl)benzenesulfonamides[P].JP:57136561,1982-08-23.(CA 1983,98:16433)
10 Gizur T,Toerley J,Fogassy E,et al.Benzenesulphonamides and process for their preparation[P].WO:2004022532,2004-03-18.(CA 2004,140:253341)
引证文献2
1 胡猛,张福利,谢美华.盐酸坦索罗辛合成路线图解[J] .中国医药工业杂志,2006,37(6):430-432. 被引量:3
2 高苏亚,李华,任旭东,王黎,范涛.坦索罗辛与β-环糊精相互作用的光度法和分子模拟研究[J] .分析试验室,2012,31(8):12-14. 被引量:5
二级引证文献8
1 何训贵,王元,吴建才.盐酸坦索罗辛的合成[J] .中国医药工业杂志,2011,42(8):565-568. 被引量:2
2 刘金平,刘文峥.盐酸坦索罗辛的合成[J] .现代药物与临床,2013,28(2):123-125. 被引量:1
3 高苏亚,李华,郭林新,刘鑫,刘常军,张航,程芳,戴佳伶.光度法研究双醋瑞因与环糊精的包合作用[J] .应用化工,2013,42(10):1751-1753.
4 岳园园,董巧,刘任,刘建明,姬汉轩.光谱法及分子模拟研究三唑类化合物与人血清白蛋白的相互作用[J] .分析试验室,2013,32(11):21-24. 被引量:5
5 高苏亚,李华,刘常军,张航,程芳,王冰.区带毛细管电泳法测定原料及其缓释胶囊中坦索罗辛[J] .分析试验室,2014,33(2):158-161.
6 高苏亚,王黎,范涛,李华.姜黄素与HP-β-CD的包合作用机理及理化性质探讨[J] .化学试剂,2014,36(5):389-391.
7 裴贵珍,陈文,马世俊,张淑兰,郭鑫.孜然挥发油β-环糊精包合物的制备与评价[J] .中成药,2015,37(2):416-419. 被引量:10
8 朱安国,王洪刚,董维超,郭勤芳,张贵民.盐酸坦洛新合成工艺优化[J] .中国医药工业杂志,2019,50(3):280-283.
1 许铁男.国外上市新药三则[J] .化学医药工业信息,1993(1):26-26.
2 刘诗通.1991年日本上市新药[J] .医药情报,1992(4):21-29.
3 上市新药[J] .世界临床药物,2011,32(10):640-640.
4 郑绳一.1994年上市新药的预测[J] .上海医药,1994(4):39-40.
5 廖斌,张莉,廖清江.2001年世界上市的新药[J] .药学进展,2002,26(3):190-192. 被引量:3
6 罗青波.日本上市新药[J] .化学医药工业信息,1992(6):35-37.
7 国外上市新药[J] .国外医药(合成药.生化药.制剂分册),1989,10(1):49-53.
8 国外上市新药[J] .国外医药(合成药.生化药.制剂分册),1989,10(2):108-111. 被引量:2
9 陆美贞.生长抑素 奥曲肽(Octreotide)[J] .国外医药(合成药.生化药.制剂分册),1990,11(2):116-118. 被引量:2
10 改变司他夫定结构可增强抗病毒活性[J] .中国医药工业杂志,2004,35(8):510-510.
;